Distinguishing COVID-19 from influenza with rapid 15-minute diagnostics
- Funded by Health Research Council of New Zealand
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$119,907.7Funder
Health Research Council of New ZealandPrincipal Investigator
Mr. John MackayResearch Location
New ZealandLead Research Institution
Dnature Diagnostics & ResearchResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Diagnostic testing is critical for the containment of COVID-19 and other infectious diseases. Due to the current complexity of the tests and thus capacity limits, testing is typically limited to those meeting certain threshold criteria. In addition, test results may take up to 48 hours to be returned to parts of New Zealand by the time samples reach the lab, the work is completed, and the results returned. Therefore, the danger exists that a disease will spread faster than the testing can help isolate positive cases. This work aims to develop rapid (15minute) molecular diagnostics that can be performed anywhere without the need for DNA instrumentation. Results will be collected and reported centrally via a smart phone app for further follow-up and confirmation. Such a method will be amenable to any new virus to ensure rapid and consistent diagnostics can be performed anywhere in New Zealand within a short time-frame.